Fatal multiorgan failure due to yellow fever vaccine-associated viscerotropic disease

被引：62

作者：

Belsher, Jon L. ^{[1
]}

Gay, Peter ^{[1
]}

Brinton, Margo ^{[2
]}

DellaValla, Joseph ^{[3
]}

Ridenour, Robert ^{[1
]}

Lanciotti, Robert ^{[4
]}

Perelygin, Andrey ^{[2
]}

Zaki, Sherif ^{[5
]}

Paddock, Christopher ^{[5
]}

Querec, Troy ^{[6
]}

Zhu, Tuofu ^{[7
]}

Pulendran, Bali ^{[6
]}

Eidex, Rachel B.

Hayes, Edward ^{[4
]}

机构：

[1] Mayo Clin, Coll Med, Rochester, MN 55905 USA

[2] Georgia State Univ, Atlanta, GA USA

[3] Portage Hlth Syst, Hancock, MI USA

[4] Ctr Dis Control & Prevent, Ft Collins, CO USA

[5] Ctr Dis Control & Prevent, Atlanta, GA USA

[6] Emory Vaccine Ctr, Atlanta, GA USA

[7] Univ Washington, Seattle, WA USA

来源：

VACCINE | 2007年 / 25卷 / 50期

关键词：

yellow fever; yellow fever vaccine-associated viscerotropic disease; yellow fever vaccination;

D O I：

10.1016/j.vaccine.2007.08.061

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

Yellow fever vaccine-associated viscerotropic disease (YEL-AVD) is a rare complication of yellow fever (YF) vaccination. A previously healthy 22-year-old female died following YF vaccination despite aggressive measures. Serial viral load titers, cytokine levels and host genetic factors were evaluated in an attempt to understand this unusual and lethal outcome. The patient's high-titer vaccine viremia and possibly related minor genetic anomalies provide clues to exploring the etiology of YEL-AVD. (c) 2007 Elsevier Ltd. All rights reserved.

引用

收藏

页码：8480 / 8485

页数：6

相关论文

共 23 条

[1] Variation in antiviral 2′,5′-oligoadenylate synthetase (2′5′AS) enzyme activity is controlled by a single-nucleotide polymorphism at a splice-acceptor site in the OAS1 gene [J].

Bonnevie-Nielsen, V ;

Field, LL ;

Lu, S ;

Zheng, DJ ;

Li, M ;

Martensen, PM ;

Nielsen, TB ;

Beck-Nielsen, H ;

Lau, YL ;

Pociot, F .

AMERICAN JOURNAL OF HUMAN GENETICS, 2005, 76 (04) :623-633

[2] LYMPHOCYTIC 2',5'-OLIGOADENYLATE SYNTHETASE-ACTIVITY INCREASES PRIOR TO THE APPEARANCE OF NEUTRALIZING ANTIBODIES AND IMMUNOGLOBULIN-M AND IMMUNOGLOBULIN-G ANTIBODIES AFTER PRIMARY AND SECONDARY IMMUNIZATION WITH YELLOW-FEVER VACCINE [J].

BONNEVIENIELSEN, V ;

HERON, I ;

MONATH, TP ;

CALISHER, CH .

CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 1995, 2 (03) :302-306

[3] Yellow fever vaccine-associated viscerotropic disease and death in Spain [J].

Doblas, A. ;

Domingo, C. ;

Bae, H. G. ;

Bohórquez, C. L. ;

de Ory, F. ;

Niedrig, M. ;

Mora, D. ;

Carrasco, F. J. ;

Tenorio, A. .

JOURNAL OF CLINICAL VIROLOGY, 2006, 36 (02) :156-158

[4] History of thymoma and yellow fever vaccination [J].

Eidex, RB .

LANCET, 2004, 364 (9438) :936-936

[5]

Gerasimon G, 2005, SOUTH MED J, V98, P653, DOI 10.1097/01.SMJ.0000157537.11806.DC

[6] CCR5 deficiency increases risk of symptomatic West Nile virus infection [J].

Glass, WG ;

McDermott, DH ;

Lim, JK ;

Lekhong, S ;

Yu, SF ;

Frank, WA ;

Pape, J ;

Cheshier, RC ;

Murphy, PM .

JOURNAL OF EXPERIMENTAL MEDICINE, 2006, 203 (01) :35-40

[7] Immunohistochemical evidence of Clostridium sp, Staphylococcus aureus, and group A Streptococcus in severe soft tissue infections related to injection drug use [J].

Guarner, Jeannette ;

Bartlett, Jeanine ;

Reagan, Sarah ;

Fischer, Marc ;

Finn, Stephen ;

O'Briain, D. Sean ;

Black, Marjorie ;

Hood, John ;

Zaki, Sherif R. .

HUMAN PATHOLOGY, 2006, 37 (11) :1482-1488

[8] Polymorphisms of interferon-inducible genes OAS-1 and MxA associated with SARS in the Vietnamese population [J].

Hamano, E ;

Hijikata, M ;

Itoyama, S ;

Quy, T ;

Phi, NC ;

Long, HT ;

Ha, L ;

Van Ban, V ;

Matsushita, I ;

Yanai, H ;

Kirikae, F ;

Kirikae, T ;

Kuratsuji, T ;

Sasazuki, T ;

Keicho, N .

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2005, 329 (04) :1234-1239

[9] ANALYSIS OF A YELLOW-FEVER VIRUS ISOLATED FROM A FATAL CASE OF VACCINE-ASSOCIATED HUMAN ENCEPHALITIS [J].

JENNINGS, AD ;

GIBSON, CA ;

MILLER, BR ;

MATHEWS, JH ;

MITCHELL, CJ ;

ROEHRIG, JT ;

WOOD, DJ ;

TAFFS, F ;

SIL, BK ;

WHITBY, SN ;

WHITBY, JE ;

MONATH, TP ;

MINOR, PD ;

SANDERS, PG ;

BARRETT, ADT .

JOURNAL OF INFECTIOUS DISEASES, 1994, 169 (03) :512-518

[10]

JONES EMM, 1972, B WORLD HEALTH ORGAN, V46, P653